Our capabilities

We can help to ensure your cell and gene therapies are safer, more effective, scalable, affordable and that they are successfully approved and reimbursed.

Our capabilities cover all aspects of ATMP development and commercialisation, from supporting researchers through to enabling patient access via the NHS.

ATMP process technologies

Our experienced teams of scientists, engineers and technical experts can deliver innovative ways to make your ATMP processes more cost-efficient, scalable, safe, and robust.

ATMP process technologies
Keep scrolling to discover our capabilities

Early-stage development

Work with our teams to advance your product from the laboratory to first-in-human studies and into clinical development. We can help de-risk your approach with integrated support to optimise your development programmes and also help you secure the funding needed to commercialise your innovations.

Early-stage development
Keep scrolling to discover our capabilities

Manufacturing innovation

Accelerate your advanced therapy manufacturing and supply chain needs in collaboration with our expert team and world class facilities, to ensure your processes are robust and efficient, whilst meeting all regulatory requirements.

Manufacturing innovation
Keep scrolling to discover our capabilities

NHS readiness

We coordinate the Advanced Therapy Treatment Centres (ATTC), a UK network of organisations focused on addressing the unique and complex challenges of accelerating the adoption of advanced therapy medicinal products (ATMPs) into the NHS.

Facilitating NHS adoption of ATMPs
Keep scrolling to discover our capabilities

Health Economics and Market Access (HEMA)

Establishing a robust pricing and reimbursement strategy early in ATMP development is essential due to high manufacturing and delivery costs. Our team of experts are on hand to help you assess and navigate the process to a successful pricing strategy.

Health Economics and Market Access (HEMA)
Keep scrolling to discover our capabilities

Regulatory affairs

ATMPs present unique regulatory challenges and our Regulatory Affairs team support developers to address specific risks in their product development, navigate the UK, EU and international regulatory landscape and satisfy the relevant national and international legislation and guidance.

Regulatory affairs
Keep scrolling to discover our capabilities

Non-clinical studies

Our non-clinical team helps you address the in silico, in vitro and in vivo scientific and regulatory evidence to help streamline your therapy’s development in an ethical and regulatory compliant manner

Non-clinical support
Keep scrolling to discover our capabilities

Skills and training

Working in collaboration with the industry and UK Government we have built a unique set of initiatives focused on delivering the upskilled and talented individuals essential to the growth of the ATMP sector.

Skills & training